Our group, working with partially deficient IGF-1 mice, has demonstrated that the liver is capable of expressing IGF-1R (which under physiological conditions it does not [99]) as a defence mechanism (peer review)
Each body is unique, and outcomes are based on lifestyle, health requirements, and continued medical care
Infection Risk: Like any shot, there is a tiny risk of infection if the area is not kept sterile
The way patients perceive changes in their treatment can have a significant impact on outcomes, as some may delay seeking medical advice or adjusting their treatment regimen without consulting a healthcare professional
14 weeks Reduced tingling & burning for some patients 23 months Better sensation, improved balance, reduced pain 6 months+ Nerve repair and long-term function improvement Severe or long-standing neuropathy may require ongoing treatment